Soy protein foods could lose the heart health claim status that was granted in 1999 if the FDA moves forward with a proposal for revocation. Despite studies supporting the cholesterol-lowering effects of soy from multiple meta-analyses from 1995 to current times, the agency has expressed concerns that the effects ofRead
The FDA is currently reviewing a proposal to revoke the cardiovascular health claim for soy foods. Is the revocation warranted? Researchers at the University of Toronto say no. The research, published in the Journal of the American Heart Association, have found a consistent cholesterol-lowering effect for soy foods protein, withRead
Glucosamine is a popular non-vitamin, non-mineral supplement widely used for osteoarthritis and joint pain. While the effectiveness of glucosamine in patients with osteoarthritis and joint pain is well known, emerging evidence from epidemiological studies suggests that glucosamine could have a role in preventing cardiovascular disease (CVD) and reducing mortality. A previousRead
In recent months the humble egg has taken a beating. In April, a study suggested that daily egg consumption posed a heart health risk. A new study from Finland, published in the American Journal of Clinical Nutrition, counters this theory and shows that a moderately high intake of dietary cholesterolRead
In April, 2019, new research from the Brigham and Women’s Hospital and Harvard Medical School in Boston, MA, reported that women with low-LDL levels below 100 mg/dl may be more at risk of hemorrhagic (bleeding) stroke. This less common type of stroke than ischemic stroke is more difficult to treatRead
Do you ask your patients if they have experienced a stress related event or trauma. This new study shows that you may want to carefully watch these patients, especially within 6 months of the event. Stress related disorders – conditions triggered by a significant life event or trauma – mayRead
In this study, researchers discovered that a simple extract from the amla plant ((Emblica officinalis, Indian gooseberry), could be a supportive therapy for dyslipidemia, a frequently implicated risk factor for development of atherosclerosis. This study was published in BMC, Complementary and Alternative Medicine. A previously published pilot study, by AntonyRead
Seventy million Americans are eligible to take cholesterol-lowering statins. Yet as many as 20% of outpatients receiving HMG-CoA reductase inhibitors (statins) experience treatment reluctance because of side effects. This leaves a large population at increased risk of cardiovascular disease (CVD). One solution is foods to reduce LDL-C. A study, presentedRead
This study shows a novel method to decrease systolic blood pressure. During this study, published in the European Journal of Preventative Cardiology, participants were exposed to 30 minutes of whole-body blue light at approximately 450 nanometres, a dose comparable to daily sunlight – followed by exposure to a control lightRead
Within the last 2 years, major guidelines have been issued from U.S.-based and European organizations that differ in their recommendations for the diagnosis and treatment of hypertension. In 2017, the American College of Cardiology in United States issued new guidelines for hypertension. They are as follows: In Europe, The TaskRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
